A new study done by Navigant Research shows some very promising numbers for the lithium-ion battery market, specifically in cars.
The study was focused on battery electric vehicles (BEVs) and which advancements in lithium battery technology will drive growth in the market.
First, the study noted that the biggest boost would come from new lithium batteries that add range and reduce the cost of BEVs. Tesla (NASDAQ:TSLA) is the front-runner here, as I’m sure you know, and competition from Nissan (TYO:7201), Chevrolet (NYSE:GM), and Volkswagen (OTC:VLKAY) are expanding the reach of the market exponentially.
According to Navigant, this growth will come mainly from high-end vehicles with long drive-ranges, as well as more affordable models with improving drive-ranges. Make no mistake, Tesla is following this exact model with its transition from the $100,000 Model S to the $35,000 Model 3.
The best source of growth, of course, will be the reduced cost in the lithium batteries, and thus in the cars themselves.
“The push by automotive original equipment manufacturers (OEMs) and battery manufacturers to continually reduce battery pack costs continues,” said Navigant senior research analyst, William Tokash.
The report estimates that technological innovation, product spread, and cost reduction will cause the lithium-ion vehicle battery market to grow from its current value of $7.8 billion to $30.6 billion by 2024.
That’s less than 10 years for nearly 4x growth; and it’s hardly a stretch given the world’s ongoing transition into cleaner energy sources.
To continue reading…
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.